Midlife measurements of plasma amyloid-beta may predict risk for mild cognitive impairment, dementia in late life
THURSDAY, Aug. 5, 2021 (HealthDay News) — Plasma concentrations of amyloid-beta at midlife are associated with the risk for mild cognitive impairment (MCI) and dementia later in life, according to a study published online Aug. 4 in Neurology.
Kevin J. Sullivan, Ph.D., M.P.H., from the University of Mississippi Medical Center in Jackson, and colleagues examined the association between midlife plasma Aß and the risk for MCI and dementia. In a subsample of the Atherosclerosis Risk in Communities cohort study, plasma Aß42 and Aß40 were measured retrospectively for 2,284 participants.
The researchers found that each doubling of midlife Aß42:Aß40 was associated with a significantly lower risk for MCI/dementia (relative risk ratio, 0.63), only up to about the median (spline model threshold, 0.20). Each standard deviation increase in plasma Aß42 (10 pg/mL) was associated with a lower risk for MCI-dementia (relative risk ratio, 0.87), while a higher risk for MCI/dementia was seen with every standard deviation increase in plasma Aß40 (67 pg/mL; relative risk ratio, 1.15). When repeating models using late-life plasma Aß predictors, the associations were comparable but slightly weaker statistically.
“A doubling of this ratio under this threshold at midlife was associated with a 37 percent lower risk of MCI or dementia, which is comparable to about five years of younger age, and a doubling of this ratio under this threshold at late life was comparable to about three years younger age,” Sullivan said in a statement. “Amyloid in the blood may be useful as a biomarker for risk of future cognitive impairment.”
Several authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
One-Hour Cognitive Test Provides Meaningful Information Beyond Traditional Memory Screening
β3 Agonists Do Not Cut Dementia Risk Versus Anticholinergics in OAB
Healthy Sleep May Protect Brain Health From Cardiometabolic Disease Risk Factors
More Extensive Deposits of Tau Seen in Early-Onset Alzheimer Disease
CTE Pathology Found in Nearly 75 Percent of Deceased Former NFL Players
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia